We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Advances in the Understanding of Etiology (I)
-
1. Infection and autoimmunity: a two-way relationship
- Dr. Ricard Cervera
-
2. Autoimmunity and atherosclerosis
- Prof. Johan Frostegard
-
3. Endothelium and autoimmunity
- Prof. Pier Luigi Meroni
- Advances in the Understanding of Etiology (II)
-
4. Prolactin has a pathogenic role in systemic lupus erythematosus
- Prof. Luis Jara-Quezada
-
5. Sjögren's syndrome: current knowledge and future prospects
- Prof. Athanasios G. Tzioufas
-
6. Genetic and environmental triggers of autoimmune thyroid diseases
- Prof. Yaron Tomer
- Advances in Pathogenesis and Clinical Manifestation
-
8. Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes
- Dr. Luís Eduardo Coelho Andrade
-
9. Pathogenic mechanisms of autoantibodies: antibodies to intracellular and membrane-bound antigens
- Dr. Luís Eduardo Coelho Andrade
-
10. What causes primary biliary cholangitis?
- Dr. M. Eric Gershwin
-
11. Capillaroscopy in autoimmune rheumatic diseases
- Prof. Maurizio Cutolo
- Advances in Diagnostic Methodologies (I)
-
12. The past, present & future of ANA testing: history and challenges of ANA
- Prof. Marvin J. Fritzler
-
13. The past, present & future of ANA testing: changing bandwidth and future of ANA
- Prof. Marvin J. Fritzler
-
14. Diagnostic methods in autoimmunity
- Mr. Steven Binder
-
15. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
16. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 2
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
17. Novel aspects of systemic sclerosis
- Prof. Gabriele Valentini
- Advances in Diagnostic Methodologies (II)
-
18. An update on the multiple faces of celiac disease
- Prof. Aaron Lerner
-
19. Protective autoantibodies
- Prof. Elias Toubi
-
21. Rheumatic fever: a model of a post-infectious autoimmune disease
- Prof. Jorge Kalil
- Treatments of autoimmune diseases
-
22. Intravenous immunoglobulins: clinical evidence
- Prof. Shaye Kivity
- Latest Developments in the Field
-
23. Adjuvants and autoimmunity
- Dr. Eitan Israeli
-
24. Antiphospholipid syndrome (APS): from pathogenesis to treatment
- Prof. Roger Levy
-
25. Vitamin D and autoimmunity
- Dr. Shir Azrielant
-
26. Pregnancy in rheumatic diseases
- Prof. Pier Luigi Meroni
- Archived Lectures *These may not cover the latest advances in the field
-
27. Pathogenic mechanisms of autoantibodies
- Prof. Cees Kallenberg
-
28. B lymphocytes on the frontline of autoimmunity
- Prof. Pierre Youinou
-
29. Apoptotic cell clearance deficiency
- Prof. Martin Herrmann
-
30. Auto-antibodies as predictors of autoimmune disease
- Dr. Nicola Bizzaro
-
31. Innate immunity and natural autoantibodies
- Prof. Luc Mouthon
-
32. Accelerated atherosclerosis in autoimmune rheumatic disease
- Dr. Andrea Doria
-
33. Pregnancy in autoimmune rheumatic diseases
- Prof. Angela Tincani
-
36. Immunologic mechanisms in systemic lupus erythematosus
- Prof. Kok-Yong Fong
-
37. Osteoimmunology
- Prof. João Eurico Fonseca
- Ms. Joana Caetano-Lopes
-
38. ANCA-associated systemic vasculitides
- Prof. Loic Guillevin
-
39. The common origin for diverse autoimmune diseases
- Prof. Juan-Manuel Anaya
-
40. Anti-cytokine therapy in rheumatoid arthritis
- Prof. Piercarlo Sarzi-Puttini
-
41. Sjogren's syndrome: autoimmune epithelitis
- Prof. Haralampos Moutsopoulos
-
42. Vitamin D and autoimmunity
- Dr. Howard Amital
-
43. Intravenous immunoglobulins: myth and reality
- Prof. Zera Tellier
Printable Handouts
Navigable Slide Index
- Introduction
- Points to be addressed
- Conceptual paradigms in medicine evolve along history
- Supernatural and mystical paradigm
- Rational, observational, and scientific paradigm (1)
- Rational, observational, and scientific paradigm (2)
- Rational, observational, and scientific paradigm (3)
- Trends and paradigms in rheumatology and autoimmunity
- LE-cell phenomenon
- Postulates for autoimmune diseases
- Autoantibodies in autoimmune diseases
- Autoantibodies against chromatin antigens in SLE
- Autoantibodies against centromere proteins in SS
- Autoantibodies against tRNA synthetase in polymyositis
- Re-definition of celiac disease clinical spectrum
- Different antibodies in different autoimmune diseases
- Association between autoantibody and disease (1)
- Association between autoantibody and disease (2)
- Antigen modification
- Autoantibodies recognizing rods and rings structures
- Anti-rods and rings antibodies in HCV patients
- Anti-rods and rings antibodies recognize IMPDH-2
- Ribavirin induces polymerization of IMPDH-2
- Anti-IMPDH-2 antibodies develop along ribavirin treatment
- Tolerance to IMPDH2
- Sjögren’s syndrome
- SS-B/La mRNA expression in patients
- SS-A/Ro mRNA expression in patients
- Hyper expression of autoantigens in target tissues
- Autoantigens in scleroderma - nucleolus
- Autoantigens are involved in protein synthesis
- Possible roles of autoantibodies in autoimmune diseases (1)
- Association between autoantibodies and HLA
- Possible roles of autoantibodies in autoimmune diseases (2)
- Tolerance breakdown and autoimmunization
- Autoantibodies and clinical manifestations
- Temporal dissociation in autoimmunity
- Autoantibodies in rheumatoid arthritis (RA)
- Anti-CCP2 titer increases in RA
- The frequency of positive results for each ACPA increases
- Elevated cytokines in RA
- Autoantibodies precede primary biliary cirrhosis for decades
- Humoral autoimmune response in primary biliary cholangitis
- Anti-PDC-E2 increases in pre-clinical stages and PBC
- Anti-PDC-E2 avidity increases in pre-clinical stages and in PBC
- Increased number of autoantibodies in PBC
- Enhanced liver fibrosis (ELF) score
- ELF score in PBC and AMA+ BN
- ELF score correlates with AMA serum levels in BN individuals
- Lessons from pre-clinical studies in autoimmunity
Topics Covered
- Autoantibodies as important elements in the definition of the autoimmunity concept
- Basis for the association of autoantibodies and autoimmune diseases
- Autoantibodies that exert direct pathogenic effects and damage target tissues
- Autoantibodies targeting extracellular antigens
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Andrade, L.E.C. (2020, June 30). Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 3, 2024, from https://doi.org/10.69645/GWGY1181.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes
Published on June 30, 2020
20 min
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Luis Andrade.
I am an Associate Professor at Universidade Federal de Sao Paulo in Brazil.
I am also a medical consultant in immunology at Fleury Laboratory
and the Chair of the Quality Assessment and Standardization Committee at IUIS.
Today, we're going to talk about pathogenic mechanisms of autoantibodies.
0:27
In this lecture, I will show how autoantibodies
have been instrumental to the establishment of
the concept of autoimmunity and to the shaping of
the clinical spectrum of several autoimmune diseases.
Then I will explore the possible reasons for
the tight association between autoantibodies and autoimmune diseases.
Finally, I will explore the several mechanisms by
which autoantibodies play a pathogenic role.
0:55
Along the millennia, medicine has been going through
a continuous evolution in conceptual paradigms.
1:03
In ancient medicine, there was a prevailing supernatural and mystical paradigm.
1:11
Progressively, the conceptual paradigm evolved on
the basis of rational and objective exploration and experimentation,
and the establishment of
a scientific paradigm,
1:25
that contributed to the development of the current classification of
diseases and establishment of laboratory biomarkers for diagnosis and
monitoring, as well as the guiding for clinical examination.
Hide